Macrophage-directed Therapies Summit 2021
Evvnt Promotion / evvnt
Archivo
28.09.2021 - 30.09.2021 Online
Time: 9:00 am - 5:00 pm
Temas de la conferencia
The annual Macrophage-directed Therapies Summit returns as the leading industry focused summit dedicated to delivering clinical proof of concept through the effective translation of macrophage-directed therapies whilst ensuring safety, control and effective combination strategies.
The annual Macrophage-directed Therapies Summit returns as the leading industry focused summit dedicated to delivering clinical proof of concept through the effective translation of macrophage-directed therapies whilst ensuring safety, control and effective combination strategies.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/784998-0?pid=4832
Speakers: Laura Helming, Head Myeloid Cell Research, Translational Innovation Platform Oncology and Immuno-Oncology, Merck and more
Brochure: https://go.evvnt.com/784998-0?pid=4832
Speakers: Laura Helming, Head Myeloid Cell Research, Translational Innovation Platform Oncology and Immuno-Oncology, Merck and more
Información e inscripción:
https://go.evvnt.com/784998-1?pid=4832
Mr. Macrophage-directed Therapies Team
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Drug Developers (Earlybird rates, focus day and workshops available): USD 2099.00, Academic (Earlybird rates and workshops available): USD 1899.00, Service Providers (Earlybird rates and workshops available): USD 2499.00
Drug Developers (Earlybird rates, focus day and workshops available): USD 2099.00, Academic (Earlybird rates and workshops available): USD 1899.00, Service Providers (Earlybird rates and workshops available): USD 2499.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
